These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17218947)

  • 1. The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferon gamma antitumor therapy.
    Van Roy M; Wielockx B; Baker A; Libert C
    Cancer Gene Ther; 2007 Apr; 14(4):372-9. PubMed ID: 17218947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of zinc against tumor necrosis factor induced lethal inflammation depends on heat shock protein 70 and allows safe antitumor therapy.
    Van Molle W; Van Roy M; Van Bogaert T; Dejager L; Van Lint P; Vanlaere I; Sekikawa K; Kollias G; Libert C
    Cancer Res; 2007 Aug; 67(15):7301-7. PubMed ID: 17671199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis.
    Elezkurtaj S; Kopitz C; Baker AH; Perez-Cantó A; Arlt MJ; Khokha R; Gansbacher B; Anton M; Brand K; Krüger A
    J Gene Med; 2004 Nov; 6(11):1228-37. PubMed ID: 15390257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and -2 in ischemic brain injury.
    Magnoni S; Baker A; Thomson S; Jordan G; George SJ; McColl BW; McCulloch J; Horsburgh K
    Gene Ther; 2007 Apr; 14(7):621-5. PubMed ID: 17235293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of tolerance allows separation of lethal and antitumor activities of tumor necrosis factor in mice.
    Takahashi N; Brouckaert P; Fiers W
    Cancer Res; 1991 May; 51(9):2366-72. PubMed ID: 1826631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of IFNgamma to tumor vessels uncouples antitumor from counterregulatory mechanisms.
    Curnis F; Gasparri A; Sacchi A; Cattaneo A; Magni F; Corti A
    Cancer Res; 2005 Apr; 65(7):2906-13. PubMed ID: 15805293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated delivery of human IFNgamma gene inhibits prostate cancer growth.
    Zhao P; Zhu YH; Wu JX; Liu RY; Zhu XY; Xiao X; Li HL; Huang BJ; Xie FJ; Chen JM; Ke ML; Huang W
    Life Sci; 2007 Aug; 81(9):695-701. PubMed ID: 17714738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in mice.
    Van Roy M; Van Lint P; Van Laere I; Wielockx B; Wilson C; López-Otin C; Shapiro S; Libert C
    Mol Cancer Ther; 2007 Sep; 6(9):2563-71. PubMed ID: 17876053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.
    Wielockx B; Lannoy K; Shapiro SD; Itoh T; Itohara S; Vandekerckhove J; Libert C
    Nat Med; 2001 Nov; 7(11):1202-8. PubMed ID: 11689884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
    Bendrik C; Robertson J; Gauldie J; Dabrosin C
    Cancer Res; 2008 May; 68(9):3405-12. PubMed ID: 18451168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving TNF as a cancer therapeutic: tailor-made TNF fusion proteins with conserved antitumor activity and reduced systemic side effects.
    Gerspach J; Pfizenmaier K; Wajant H
    Biofactors; 2009; 35(4):364-72. PubMed ID: 19484741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells.
    Sanchez-Perez L; Gough M; Qiao J; Thanarajasingam U; Kottke T; Ahmed A; Thompson JM; Maria Diaz R; Vile RG
    Gene Ther; 2007 Jul; 14(13):998-1009. PubMed ID: 17443216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of antimetastatic activity of interferon and tumor necrosis factor by heparin.
    Sylvester DM; Liu SY; Meadows GG
    Immunopharmacol Immunotoxicol; 1990; 12(2):161-80. PubMed ID: 2121817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.
    Mena S; Benlloch M; Ortega A; Carretero J; Obrador E; Asensi M; Petschen I; Brown BD; Estrela JM
    Clin Cancer Res; 2007 May; 13(9):2658-66. PubMed ID: 17473197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-dose tumor necrosis factor-alpha in combination with STEALTH liposomal cisplatin (SPI-077) on soft-tissue- and osteosarcoma-bearing rats.
    Hoving S; van Tiel ST; Eggermont AM; ten Hagen TL
    Anticancer Res; 2005; 25(2A):743-50. PubMed ID: 15868905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged exposure to IL-1beta and IFNgamma induces necrosis of L929 tumor cells via a p38MAPK/NF-kappaB/NO-dependent mechanism.
    Vercammen E; Staal J; Van Den Broeke A; Haegman M; Vereecke L; Schotte P; Beyaert R
    Oncogene; 2008 Jun; 27(27):3780-8. PubMed ID: 18246123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmopressin reduces melanoma lung metastasis in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1.
    Ripoll GV; Farina HG; Yoshiji H; Gomez DE; Alonso DF
    In Vivo; 2006; 20(6B):881-5. PubMed ID: 17203783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy.
    Sega EI; Lu Y; Ringor M; Leamon CP; Low PS
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):559-66. PubMed ID: 18411004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligonucleotides against TNFR1 prevent toxicity of TNF/IFNγ treatment in mouse tumor models.
    Van Hauwermeiren F; Vandenbroucke RE; Grine L; Puimège L; Van Wonterghem E; Zhang H; Libert C
    Int J Cancer; 2014 Aug; 135(3):742-50. PubMed ID: 24382818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma.
    Agorio C; Schreiber F; Sheppard M; Mastroeni P; Fernandez M; Martinez MA; Chabalgoity JA
    J Gene Med; 2007 May; 9(5):416-23. PubMed ID: 17410612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.